Your browser doesn't support javascript.
loading
Radiation Followed by OX40 Stimulation Drives Local and Abscopal Antitumor Effects in an Anti-PD1-Resistant Lung Tumor Model.
Niknam, Sharareh; Barsoumian, Hampartsoum B; Schoenhals, Jonathan E; Jackson, Heather L; Yanamandra, Niranjan; Caetano, Mauricio S; Li, Ailin; Younes, Ahmed I; Cadena, Alexandra; Cushman, Taylor R; Chang, Joe Y; Nguyen, Quynh N; Gomez, Daniel R; Diab, Adi; Heymach, John V; Hwu, Patrick; Cortez, Maria Angelica; Welsh, James W.
Afiliação
  • Niknam S; Department of Experimental Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Barsoumian HB; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Schoenhals JE; Department of Experimental Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Jackson HL; Immuno-oncology and combinations DPU, GlaxoSmithKline, Collegeville, Pennsylvania.
  • Yanamandra N; Immuno-oncology and combinations DPU, GlaxoSmithKline, Collegeville, Pennsylvania.
  • Caetano MS; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Li A; Department of Experimental Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Younes AI; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Cadena A; Department of Experimental Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Cushman TR; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Chang JY; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Nguyen QN; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Gomez DR; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Diab A; Department of Thoracic Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Heymach JV; Department of Thoracic Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Hwu P; Department of Melanoma Medical Oncology, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Cortez MA; Department of Experimental Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Welsh JW; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas. jwelsh@mdanderson.org.
Clin Cancer Res ; 24(22): 5735-5743, 2018 11 15.
Article em En | MEDLINE | ID: mdl-29784675
Assuntos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Receptores OX40 / Receptor de Morte Celular Programada 1 / Antineoplásicos Imunológicos / Neoplasias Pulmonares Tipo de estudo: Prognostic_studies Limite: Animals / Female / Humans Idioma: En Revista: Clin Cancer Res Assunto da revista: NEOPLASIAS Ano de publicação: 2018 Tipo de documento: Article
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Receptores OX40 / Receptor de Morte Celular Programada 1 / Antineoplásicos Imunológicos / Neoplasias Pulmonares Tipo de estudo: Prognostic_studies Limite: Animals / Female / Humans Idioma: En Revista: Clin Cancer Res Assunto da revista: NEOPLASIAS Ano de publicação: 2018 Tipo de documento: Article